(Updates with the latest stock price movement in the headline and the first paragraph.)
Aveanna Healthcare (AVAH) shares rose more than 20% on Thursday after the company reported better-than-expected fiscal Q2 results.
The company reported fiscal Q2 adjusted earnings Thursday of $0.22 per diluted share, up from $0.18 a year earlier.
Analysts polled by FactSet expected $0.17.
Revenue for the quarter ended July 4 was $670.5 million, up from $589.6 million a year earlier.
Analysts projected $638.6 million.
The company said it now expects full-year 2026 revenue greater than $2.68 billion, compared with a prior estimate of $2.63 billion to $2.65 billion. Analysts forecast $2.63 billion.
Price: $10.88, Change: $+1.83, Percent Change: +20.22%